Qventus
PrivateLast Round
Series D
Jan 13, 2025
Est. Valuation
$400M
Total Funding Raised
$204.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Qventus is a healthcare technology company that provides an AI-powered software platform designed to automate and optimize hospital operations.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qventus Comparables
Compare Qventus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TeleTracking Technologies | 78% | |
| Health Catalyst | 77% | |
| Apella Technology | 77% |
Qventus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 13, 2025 | ||||
| Series C Extension | Aug 10, 2022 | ||||
| Growth Equity | Feb 28, 2022 | ||||
| Series B | May 14, 2018 | ||||
| Series A | Nov 16, 2016 | ||||
Seed | Jan 1, 2015 |
Key People
Founding team and executive leadership
Qventus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kohlberg Kravis Roberts | Series D |
| StartX | Series A |
| Thomas H. Lee Partners | Growth Equity |
| Allina Health System | Series D |
| Fenox Venture Capital | Seed |
| Norwest Venture Partners | Series B, Growth Equity, Series A |
| Y Combinator | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 82% MoM, from 33K to 60K.
- Apr 26, 2026
Care Gap & Coding Automation (CGCA) product is now in beta.
Recent news
Latest coverage and updates
- signs_new_clientJul 28, 2026
Qventus, Inc signed new client OhioHealth Corporation on Jul 28th '26.
Qventus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qventus's valuation, stock price, and market status.
Is Qventus a public or private company?
Qventus is a private company.
What is the current stock price of Qventus?
Qventus is a private company with no public stock price. No recent secondary market data is available.
How much is Qventus worth (valuation)?
Qventus's valuation is estimated at $400.0M based on funding round data.
Can I buy Qventus stock?
Qventus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qventus's last funding round?
Qventus's most recent funding round was Series D on January 13, 2025.
Who are the main investors in Qventus?
Key investors in Qventus include Kohlberg Kravis Roberts, Thomas H. Lee Partners, Norwest Venture Partners, Bessemer Venture Partners, Mayfield Fund.
Will Qventus IPO soon?
No public IPO plans have been announced for Qventus.
How can I track Qventus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qventus's secondary market activity and sign up for updates.